CLINICAL_TRIALS
trial_result
· 2022-05-16
Clinical Trial Update: Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients [Phase 3]
Summary
Phase 3 trial evaluating chemoradiotherapy with or without PD-1 blockade for anal canal squamous carcinoma; status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Anal Canal Cancer Stage III, Anal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN